Longitude Capital
VC
INVESTOR TYPE
Active
STATUS
26
PROFESSIONALS
94
INVESTMENTS
31
PORTFOLIO
47
EXITS
Description
Longitude Capital is a venture capital investment firm that invests in the biotechnology and medical technology sectors. The firm specializes in seed, early stage, later stage, spin-outs, recapitalization, PIPE and structured transactions. It was founded in 2006 and is based in Menlo Park, California with additional offices in Greenwich, Connecticut and Boston, Massachusetts.
Website
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
2006
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 2740 Sand Hill Road
- Suite 200
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
Longitude Capital Investments (94)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Epirium | 18-Dec-2019 | Later Stage VC | 0000 | Biotechnology | Clinical Trials - General | 0000000 0000000 |
| 0000000 0000000000 | 22-Apr-2019 | 00000 00000 | 00000 | Biotechnology | Clinical Trials - Phase 2 | 00000 000000 00.0 |
| 0000000 0000000000 | 18-Apr-2019 | 00000 00000 | 00000 | Biotechnology | Clinical Trials - Phase 3 | 000000 00000000 |
| 0000000 000000 | 10-Apr-2019 | 00000 00000 | 000.00 | Biotechnology | Startup | |
| 0000000 0000000000 | 03-Jan-2019 | 00000 00000 | 0000 | Pharmaceuticals | Clinical Trials - Phase 1 | 000000 00000000 |
| 0000000 0000000 | 05-Dec-2018 | 00000 00000 | 00.00 | Therapeutic Devices | Generating Revenue | 0000-00000 00000000 |
| 00000 | 05-Dec-2018 | 00000 00000 | 0000 | Diagnostic Equipment | Stealth | 000000 000000 |
| 000000000 | 19-Nov-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 000000 00.0 |
| 89bio | 25-Oct-2018 | Early Stage VC | 0000 | Drug Discovery | Clinical Trials - General | 0000000 00000000 00 |
| CuraSen | 17-Oct-2018 | Early Stage VC | 000.00 | Drug Discovery | Startup | 0000000 0000000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Longitude Capital’s full profile, request a free trial.
Longitude Capital Exits (47)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Aptinyx | 13-Jan-2020 | Public Investment 2nd Offering | 000.00 | Completed |
|
| 00000 | 11-Nov-2019 | 000 | 000.00 | Completed |
|
| 0000 00000 | 01-Aug-2019 | 000000 0000000000 | 000.00 | Completed |
|
| 0000000 0000000 | 01-May-2019 | 000000000000000000 | Completed |
|
|
| 0000000 0000000 | 26-Feb-2019 | 000000000000000000 | 000 | Completed |
|
| 00000000 | 09-Jan-2019 | 000 00 00000000 | Completed |
|
|
| 0000000 0000000000 | 31-Oct-2018 | 000 | 00000 | Completed |
|
| 000000000 00000000 | 20-Sep-2018 | 000000 0000000000 | 000.00 | Completed |
|
| California Cryobank | 06-Aug-2018 | Buyout/LBO | Completed | ||
| Zavante | 24-Jul-2018 | Merger/Acquisition | 00000 | Completed |
Longitude Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Longitude Capital‘s full profile, request access.
Request full access to PitchBookLongitude Capital Team (39)
18 Former Team Members
You’re viewing 5 of 39 team members. Get the full list »Longitude Capital Co-Investors (124)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| OrbiMed | 6 | 0 | 0 |
| New Enterprise Associates | 0 | 0 | |
| Frazier Healthcare Partners | 0 | 0 | 0 |
| HBM Healthcare Investments | 0 | 0 | 0 |
| Vivo Capital | 0 | 0 |